Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 753-759

  Onali, Pierluigi ^a   Olianas, Maria C ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 11 [[4 [4 (DIETHYLAMINO)BUTYL] 1 PIPERIDYL]ACETYL] 5,11 DIHYDRO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPIN 6 ONE; 4 FLUOROHEXAHYDROSILADIFENIDOL; ADENYLATE CYCLASE; CARBACHOL; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; HEXAHYDROSILADIFENIDOL; HIMBACINE; METHACHOLINE; METHOCTRAMINE; MUSCARINIC RECEPTOR; OTENZEPAD; OXOTREMORINE; PIRENZEPINE; STAUROSPORINE; TELENZEPINE; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVATION; FRONTAL CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ACETYLCHOLINE; ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ANIMALS; CEREBRAL CORTEX; CORTICOTROPIN-RELEASING HORMONE; FRONTAL LOBE; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; MEMBRANES; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; PERTUSSIS TOXIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0032443376     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abdel-Latif AA, Yousufzai YK, De S and Tachado SD (1992) Carbachol stimulates adenylyl cyclase and phospholipase C and muscle contraction-relaxation in a reciprocal manner in dog iris sphincter smooth muscle. Eur J Pharmacol-Mol Pharmacol Sect 226:351-361.
2. Adem A and Karlsson E (1997) Muscarinic receptor subtype selective toxins. Life Sci 60:1069-1076.
3. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
4. Ashe JH and Weinberger NM (1991) Acetylcholine modulation of cellular excitability via muscarinic receptors: Functional plasticity in auditory cortex, in Activation to Acquisition: Functional Aspects of the Basal Forebrain Cholinergic System (R. T. Richardson, ed) pp 189-246, Birkauser, Boston, MA.
5. Bartus RA, Dean RL III, Beer B and Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunctions. Science (Wash DC) 217:408-417.
6. Baumgold J, Paek R and Fiskum G (1992) Calcium independence of phosphoinositide hydrolysis-induced increase in cyclic AMP accumulation in SK-N-SH human neuroblastoma cells. J Neurochem 58:1754-1759.
7. Behan DP, Heinrichs SC, Troncoso JC, Liu X-J, Kawas CH, Ling N and De Souza EB (1995) Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature (Lond) 378:284-287.
8. Bernstein G, Blank JL, Smrcka AV, Higashijima T, Sternweis PC, Exton JH and Ross EM (1992) Reconstitution of agonists-stimulated phosphatidylinositol 4,5-biphosphate hydrolysis using purified ml muscarinic receptor, Gq/11, and phospholipase C-β1. J Biol Chem 267:8081-8088.
9. Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fizpatrick FA, Smith RJ and Bunting S (1990) Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 255:756-768.
10. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
11. Brown E, Kendall DA and Nahorski SR (1984) Inositol phospholipid hydrolysis in rat cerebral cortical slices: I. Receptor characterization. J Neurochem 42:1379-1387.
12. Buckley NJ, Bonner TI and Brann MR (1988) Localization of a family of muscarinic receptors mRNAs in rat brain. J Neurosci 8:4646-4652.
13. sα and is not a consequence of phosphoinositidase C activation. Biochem J 315:883-888.
14. Caufield MP (1993) Muscarinic receptors: Characterization, coupling and function. Pharmacol Ther 58:319-379.
15. Cox CL, Metherate R and Ashe JH (1994) Modulation of cellular excitability in neocortex: Muscarinic receptor and second messenger-mediated actions of acetylcholine. Synapse 16:123-136.
16. Crawley JN, Olschowka JA, Diz DI and Jakobowitz DM (1985) Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat. Peptides 6:891-901.
17. Cronin MJ, Zysk JR and Baertschi AJ (1986) Protein kinase C potentiates corticotropin releasing factor stimulated cyclic AMP in pituitary. Peptides 7:935-938.
18. De Souza EB and Battaglia B (1986) Increased corticotropin-releasing factor receptors in rat cerebral cortex following chronic atropine treatment. Brain Res 397: 401-404.
19. 3 receptors. J Pharmacol Exp Ther 242:257-262.
20. Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E and Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptors subtypes. J Pharmacol Exp Ther 256:727-733.
21. Elhert FJ, Roeske WR and Yamamura HI (1994) Muscarinic receptors and novel strategies for the treatment of age-related brain disorders. Life Sci 55:2135-2145.
22. 3 muscarinic receptors in the rat peripheral lung. Biochem Pharmacol 52:643-658.
23. Felder CC, Kanterman RY, Ma AL and Axelrod J (1989) A transfected m1 muscarinic acetylcholine receptor stimulates adenylate cyclase via phosphoinositol hydrolysis. J Biol Chem 264:20356-20362.
24. Fisher SK and Bartus RT (1985) Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain. J Neurochem 45:1085-1095.
25. Fleming WW, Westfall DP, De La Lande S and Jellet LB (1972) Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther 181:339-345.
26. Forray C and El-Fakahany EE (1990) On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex. Mol Pharmacol 37:893-902.
27. Furuyama T, Inagaki S and Takagi H (1993) Distribution of type II adenylyl cyclase mRNA in the rat brain. Mol Brain Res 19:165-170.
28. Kapcala LP and Aguilera G (1995) Modulation of corticotropin-releasing hormone stimulated cyclic adenosine monophosphate production by brain cells. Brain Res 678:207-212.
29. Koob GF and Bloom FE (1985) Corticotropin-releasing factor and behavior. Fed Proc 44:259-263.
30. Levey AI, Kitt CA, Simonds WF, Price DL and Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11:3218-3226.
31. McCormick DA and Prince DA (1985) Two types of muscarinic response to acetylcholine in mammalian cortical neurons. Proc Natl Acad Sci USA 82:6344-6348.
32. 2 muscarinic receptors using selective antagonists: Comparison with N1E-115 muscarinic receptors. J Pharmacol Exp Ther 257:1121-1129.
33. 2+-insensitive adenylyl cyclases in the rat brain. Synapse 14:51-59.
34. s-linked neurotransmitter receptors to stimulate adenylyl cyclase activity of rat olfactory bulb. J Neurochem 61:2183-2190.
35. Paxinos G and Watson C (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, NY.
36. Salomon Y, Londos D and Robbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548.
37. Spiegel AM, Shenker A and Weinstein LS (1992) Receptor-effector coupling by G proteins: Implications for normal and abnormal signal transduction. Endocr Rev 13:536-565.
38. Tang, W-J and Gilman AG (1992) Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science (Wash DC) 254:1500-1503.
39. 4) in rat forebrain. Mol Pharmacol 38:267-273.
40. Wang SZ and El-Fakahany EE (1993) Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists. J Pharmacol Exp Ther 266:237-243.